Product Description
Since last manyyears Saintroy Lifescience is leading manufacture, export and supplierofCytarabine Injectionfrom Surat, Gujarat, India. Cytarabine Injection used in the treatment of acute myeloid leukaemia, acute lymphocytic leukaemia (ALL) and in lymphomas.
Tags: Cytarabine Injection manufacturer, Cytarabine Injection exporter,Cytarabine Injection supplier, and Cytarabine Injection, whogmp approved Cytarabine Injectionmanufacturer and supplier, Cytarabine Injection distributor, Cytarabine Injectionshipper, Cytarabine Injection 1 ml Cytarabine Injection 1 ml supplier,Cytarabine Injection 1 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility inGujarat, India.
Registration: Saintroy Lifescience is interested inregistration of own brand or customer brands in ministry of health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country :Saintroy Lifescience Cytarabine Injection Exportto USA, Canada, Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal,Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile, Somalia, Philippines,Myanmar, Maldives, Thailand, Singapore, Malaysia, Hong Kong, China, Zimbabwe,Togo, Burkina Faso, Niger,Guinea Bissau, Congo, Democratic of republic, IvoryCosta, Oman, Guatemala, Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba,Colombia, Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran,Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Broad Clinical ApplicationCytarabine Injection is indicated for the management of various leukemias, offering critical support in the treatment of acute myeloid leukemia (AML) and non-Hodgkins lymphoma. Its efficacy and targeted action make it an essential component of chemotherapy regimens.
Flexible Administration RoutesThis medication can be given intravenously, subcutaneously, or intrathecally, allowing clinicians to tailor administration based on patient needs and clinical protocols. Cytarabine is compatible with most standard infusion solutions, ensuring convenience for healthcare providers.
Safe Handling and StorageCytarabine Injection comes in sealed glass vials that must be stored in a cool, dry place to ensure drug integrity. With a shelf life of up to 2 years, it is suitable for storage in hospital and pharmacy settings without compromising effectiveness.
FAQ's of Cytarabine Injection:
Q: How should Cytarabine Injection be administered for optimal effectiveness?
A: Cytarabine Injection can be administered intravenously, subcutaneously, or intrathecally, depending on the specific condition and doctor's instructions. Only qualified healthcare professionals should perform injections to ensure patient safety and achieve the best results.
Q: What is the main benefit of using Cytarabine Injection in leukemia treatment?
A: The primary benefit of Cytarabine Injection is its proven effectiveness in treating various forms of leukemia, especially acute myeloid leukemia (AML) and non-Hodgkins lymphoma. It targets and disrupts the growth of cancer cells, contributing to improved patient outcomes.
Q: When should Cytarabine Injection be used during cancer therapy?
A: Cytarabine Injection is typically used during prescribed chemotherapy cycles, as determined by an oncologist. Dosing and schedules vary based on each patient's medical plan and disease stage.
Q: Where should Cytarabine Injection vials be stored for maximum shelf life?
A: The vials should be kept in a cool, dry place, away from direct heat and sunlight, to preserve their efficacy. Always ensure the storage area maintains consistent temperature as recommended.
Q: What safety precautions should be taken while handling Cytarabine Injection?
A: Because it is a prescription-only medication for injection, Cytarabine should only be handled and administered by healthcare professionals. Always follow institutional safety protocols, and use appropriate personal protective equipment during preparation and administration.
Q: Is Cytarabine Injection compatible with standard infusion solutions?
A: Yes, Cytarabine 100 mg/ml is formulated to be compatible with most standard infusion solutions, simplifying its incorporation into various chemotherapy regimens.